Radiopharmaceuticals Division, Bhabha Atomic Research Centre, Mumbai, 400085, India.
Homi Bhabha National Institute, Anushaktinagar, Mumbai, 400094, India.
J Pept Sci. 2020 Mar;26(3):e3241. doi: 10.1002/psc.3241. Epub 2020 Jan 26.
The dual interaction with integrins and neuropilin-1 receptor is the peculiar feature of iRGD peptide. Hence, in the present study, two iRGD peptide analogs were synthesized with DOTAGA and NODAGA as bifunctional chelator and aminohexanoic acid as a spacer for radiometalation with GaCl . Negatively charged Ga-DOTAGA-iRGD and neutral Ga-NODAGA-iRGD radiotracers were investigated through in vitro cell uptake studies and in vivo biodistribution studies. Significant internalization of radiotracers in murine melanoma B16F10 cells was observed during in vitro studies. During in vivo studies, tumor uptake was higher for neutral Ga-NODAGA-iRGD, but Ga-DOTAGA-iRGD exhibited better tumor-to-blood ratio due to faster blood clearance. High kidney uptake of the two radiotracers was the limitation, which needs to be resolved through modification either in the peptide backbone or spacer/chelator.
iRGD 肽的独特特征是与整合素和神经纤毛蛋白-1 受体的双重相互作用。因此,在本研究中,合成了两种带有 DOTAGA 和 NODAGA 的 iRGD 肽类似物作为双功能螯合剂,以及带有氨基己酸的间隔物,用于与 GaCl3 进行放射性金属化。通过体外细胞摄取研究和体内生物分布研究,研究了带负电荷的 Ga-DOTAGA-iRGD 和中性 Ga-NODAGA-iRGD 放射性示踪剂。在体外研究中观察到放射性示踪剂在鼠黑色素瘤 B16F10 细胞中的显著内化。在体内研究中,中性 Ga-NODAGA-iRGD 的肿瘤摄取率更高,但由于血液清除速度更快,Ga-DOTAGA-iRGD 的肿瘤与血液比更高。两种放射性示踪剂的高肾脏摄取是一个限制,需要通过修饰肽骨架或间隔物/螯合剂来解决。